Therapeutic Implications of Curcumin in the Treatment of Inflammatory Eye Diseases: A Review-Reference-Cited by-同舟云学术

Therapeutic Implications of Curcumin in the Treatment of Inflammatory Eye Diseases: A Review

Published:2023-03 Issue:4 Volume:24 Page:553-561
ISSN:1389-2010
Container-title:Current Pharmaceutical Biotechnology
language:en
Short-container-title:CPB

Author:

Thiruvengadam Muthu¹²,Heydari Mojtaba³,Khalili Mohammad Reza³,Nowroozzadeh Mohammad Hossein³,Bamdad Shahram³,Sahebkar Amirhossein⁴⁵,Shariati Mohammad Ali⁶

Affiliation:

1. Department of Applied Bioscience, College of Life and Environmental Sciences, Konkuk University, Seoul, 05029, Korea

2. Department of Microbiology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai 600077, India

3. Poostchi Ophthalmology Research Center, Department of Ophthalmology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

4. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

5. Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

6. K.G. Razumovsky Moscow State University of Technologies and Management (the First Cossack University), Moscow 109004, Russian Federation

Abstract

Abstract: Curcumin is the main active constituent of the medicinal plant Curcuma longa L., used traditionally as a medicinal spice in several ancient civilizations. Different preclinical and clinical studies support the anti-inflammatory properties of curcumin in various inflammatory diseases. As inflammation has an essential role in the pathophysiology of many ocular diseases, curcumin has been suggested as a promising therapeutic agent with anti-inflammatory properties. Based on the extent of experimental and clinical evidence, curcumin can exert protective effects against the corneal, uveal, retinal, optic nerve, orbital, and lacrimal gland inflammatory disorders. Herein, the available literature on the beneficial effects of curcumin in inflammatory eye diseases is reviewed. The limitations and future directions of these investigations are also discussed.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmaceutical Science,Biotechnology

Reference70 articles.

1. Prasad S.; Aggarwal B.B.; Turmeric, the golden spice: From Traditional Medicine to Modern Medicine. In: Herbal Medicine: Biomolecular and Clinical Aspects, 2nd ed; In: Benzie IFF, Wachtel- Galor S, editors. CRC Press/Taylor and Francis: Boca Raton (FL), 2011

2. Satil F.; Mikail A.; Ethnobotanical use of Stachys L. (Lamiaceae) taxa in Turkey. Int J Nat Life Sci 2020,4(2),66-86

3. Jurenka J.S.; Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research. Altern Med Rev 2009,14(2),141-153

4. Adams B.K.; Ferstl E.M.; Davis M.C.; Herold M.; Kurtkaya S.; Camalier R.F.; Hollingshead M.G.; Kaur G.; Sausville E.A.; Rickles F.R.; Snyder J.P.; Liotta D.C.; Shoji M.; Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents. Bioorg Med Chem 2004,12(14),3871-3883

5. Menon V.P.; Sudheer A.R.; Antioxidant and anti-inflammatory properties of curcumin. Adv Exp Med Biol 2007,595,105-125

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the Treatment of Diabetic Retinal Inflammatory Factors with Curcumin;Journal of Contemporary Medical Practice;2024-08-21

2. Alternative Therapies for Eye Inflammation: Patient Preferences and Patterns;International Journal of Traditional and Complementary Medicine Research;2024-04-29

3. Coumarin linked to 2-phenylbenzimidazole derivatives as potent α-glucosidase inhibitors;Scientific Reports;2024-03-28

4. THE EFFECT OF CURCUMIN ON INTRAVITREAL PROINFLAMMATORY CYTOKINES, OXIDATIVE STRESS MARKERS, AND VASCULAR ENDOTHELIAL GROWTH FACTOR IN AN EXPERIMENTAL MODEL OF DIABETIC RETINOPATHY;J PHYSIOL PHARMACOL;2023

5. Curcumin's Dose-Dependent Attenuation of Gastric Cancer Cell Progression Via the PI3K Pathway Blockade;Dose-Response;2023-10